Premium
Monitoring the Safety of Medicines Used Off‐Label
Author(s) -
Dal Pan G J
Publication year - 2012
Publication title -
clinical pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.941
H-Index - 188
eISSN - 1532-6535
pISSN - 0009-9236
DOI - 10.1038/clpt.2012.24
Subject(s) - postmarketing surveillance , adverse effect , medicine , pharmacovigilance , off label use , drug , safety profile , pharmacology
Off‐label use of medicines is common. Because many off‐label uses have not been carefully studied, it is important that postmarketing drug safety systems be able to identify, assess, and monitor adverse events that occur in the off‐label setting. The full range of postmarketing surveillance and analysis tools can be utilized to study the adverse effects of medicines used off‐label. Clinical Pharmacology & Therapeutics (2012); 91 5, 787–795. doi: 10.1038/clpt.2012.24